DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Hosford SR. et al.
Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways.
Pharmgenomics Pers Med 2014;
7: 203-215
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.